阻止WNT7A可以提高MHC-I抗原的呈现,并提高免疫检查点阻塞疗法的有效性
Jiazheng Sun1,2, Pin Wang1,2,3,4, Ziying Yi1,5
1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Cancer immunology research
|November 27, 2024
概括
在瘤中,WNT7A蛋白抑制CD8+ T细胞透. 抑制WNT7A增强MHC-I表达,增强T细胞活性和免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子生物学分子生物学
背景情况:
- 瘤中有限的CD8+ T细胞透阻碍了基于T细胞的免疫疗法的有效性.
- 导致减少CD8+T细胞瘤透的机制尚未完全理解.
研究的目的:
- 阐明WNT7A在调节CD8+T细胞透中的作用.
- 研究WNT7A作为增强癌症免疫疗法的潜在治疗标.
主要方法:
- 大量RNA测序人类瘤,以确定基因表达和CD8+T细胞透之间的相关性.
- 在体外和体内研究涉及遗传和制药抑制WNT7A.
- 对Wnt/β-catenin和NF-κB信号通路的分析.
- 对瘤细胞MHC-I表达的评估.
- 在小鼠模型中评估CD8+T细胞透,功能和抗瘤免疫力.
主要成果:
- 在人类瘤中,高WNT7A表达和降低CD8+T细胞透之间观察到强烈的相关性.
- 抑制WNT7A显著增加了MHC-I在瘤细胞上的表达,通过非活性化Wnt/β-catenin和激活NF-κB通路.
- 发现了一种新型化合物 (1365-0109),它破坏了WNT7A-FZD5的相互作用,提高了MHC-I.I.的调节.
- 在小鼠模型中抑制WNT7A增强了CD8+T细胞的透和功能,改善了抗瘤免疫力和免疫治疗反应.
结论:
- WNT7A是瘤中免疫抑制的内在机制.
- 向WNT7A提供了一个有希望的策略,以提高癌症免疫疗法的疗效,特别是免疫检查点阻塞疗法.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K